ArticleHaematologica2024

Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant.

Kebede H Begna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.